Top Markets
#1 pippin pippin +18.72%
#2 TRIA TRIA +15.94%
#3 Janction Janction +12.83%
#4 River Pts River Pts +11.77%
#5 Aria.AI Aria.AI +10.99%
#6 Osaka Protocol Osaka Protocol +10.78%
#7 DeXe DeXe +10.59%
#8 Orochi Network Orochi Network +9.93%
#9 Strategic Oil Supply Strategic Oil Supply +8.85%
#10 Infinity Ground Infinity Ground +8.45%
Coin of the day
pippin pippin
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
Novo Nordisk A/S Novo Nordisk A/S

Novo Nordisk A/S

NVO
Pozycja w akcjach #98
Novo Nordisk A/S, a healthcare company, engages in the research, development,... Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company collaboration agreements with Gilead Sciences, Inc. Novo Nordisk A/S also has a research collaboration with Lumen Bioscience, Inc. to explore strategies for delivering oral biologics for cardiometabolic disease. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
Cena akcji
$37.45
Kapitalizacja rynkowa
$166.43B
Zmiana (1 dzień)
-2.55%
Zmiana (1 rok)
-53.09%
Kraj
DK
Handel Novo Nordisk A/S (NVO)

Kategoria

Healthcare
Historia ceny akcji dla Novo Nordisk A/S (NVO)
Najwyższa cena zamknięcia: $39.09 dnia 2026-03-01

Najniższa cena zamknięcia: $2.18 dnia 2001-06-01
Historia cen akcji firmy Novo Nordisk A/S od 2001 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) 18.12%
2025 -52.88%
2024 4.19%
2023 52.36%
2022 18.41%
2021 58.33%
2020 21.90%
2019 25.31%
2018 -13.26%
2017 49.00%
2016 -38.01%
2015 27.36%
2014 25.80%
2013 10.08%
2012 42.99%
2011 5.13%
2010 62.76%
2009 25.56%
2008 -19.27%
2007 58.83%
2006 48.57%
2005 3.61%
2004 36.73%
2003 27.97%
2002 -21.30%
2001 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $451.59 -11.89%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
 $744.12 10.67%
US
UCB SA UCB SA
UCB SA
UCB.BR
 $296.06 50.53%
BE
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $94.95 -40.77%
AU
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $684.77 10.45%
NL